V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007074 | 320003963 | 1.6 | 68.2 | Palliative (P) | 2015-06-12 | 2015-06-12 | CISPLATIN + ETOPOSIDE | 2 | N | 320023143 | OLAPARIB |
| 320007075 | 320003968 | 1.71 | 48 | Palliative (P) | 2018-11-21 | 2018-11-30 | Docetaxel | null | N | 320023192 | CISPLATIN + GEMCITABINE |
| 320007076 | 320003971 | 1.78 | 91.9 | Curative (C) | 2017-04-23 | 2017-04-26 | PEMBROLIZUMAB | 02 | N | 320023195 | DOCETAXEL |
| 320007077 | 320005824 | 1.79 | null | Adjuvant (A) | 2016-08-12 | 2016-08-16 | TEMOZOLOMIDE | N | N | 320023276 | IMATINIB |
| 320007078 | 320003988 | 1.71 | 68.8 | Curative (C) | 2014-11-18 | 2014-12-09 | Etoposide oral | null | null | 320023379 | TOPOTECAN |
| 320007079 | 320003991 | null | 60 | Palliative (P) | 2015-11-15 | 2015-11-19 | Cetuximab + Radiotherapy Maint | 2 | N | 320023393 | CAPECITABINE + CARBOPLATIN |
| 320007080 | 320006708 | 1.78 | 78 | Palliative (P) | 2015-11-09 | 2015-11-10 | Y-90 | N | N | 320023433 | TEMOZOLOMIDE |
| 320007081 | 320003999 | 1.81 | 65.1 | Palliative (P) | 2017-04-30 | 2017-05-07 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | N | 320023507 | PEMBROLIZUMAB |
| 320007082 | 320004005 | 1.7 | 69 | Curative (C) | 2018-04-14 | 2018-04-14 | ICON8 TRIAL | 2 | N | 320023538 | PEMBROLIZUMAB |
| 320007083 | 320004007 | 1.69 | 60 | Palliative (P) | 2018-01-09 | 2018-01-14 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 320023546 | TEMOZOLOMIDE |
| 320007084 | 320004008 | 1.72 | 72 | Palliative (P) | 2015-04-26 | 2015-04-27 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 320023562 | BENDAMUSTINE + RITUXIMAB |
| 320007085 | 320004014 | 1.78 | 68.7 | Curative (C) | 2014-04-06 | 2014-05-24 | Oxaliplatin + Modified de Gramont | N | N | 320023661 | CARBOPLATIN + VINORELBINE |
| 320007086 | 320004017 | 1.71 | 95.5 | Palliative (P) | 2014-04-30 | 2014-05-18 | POUT TRIAL | N | N | 320023680 | MITOMYCIN INTRAVESICULAR |
| 320007087 | 320004020 | 1.79 | 77.8 | Palliative (P) | 2016-10-01 | 2016-10-15 | Mitomycin Intravesical | N | N | 320023682 | PEMBROLIZUMAB |
| 320007088 | 320004029 | 1.79 | 87.6 | Neo-adjuvant (N) | 2017-12-31 | 2018-01-02 | LOMUSTINE + PROCARBAZINE | N | N | 320023709 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 320007089 | 320005849 | 1.7 | null | Palliative (P) | 2014-08-20 | 2015-02-19 | CARBOPLATIN + RT | 2 | N | 320023794 | NIVOLUMAB |
| 320007090 | 320004040 | 1.73 | null | Palliative (P) | null | 2018-06-04 | PEMBROLIZUMAB | null | null | 320023838 | DOXORUBICIN + GEMCITABINE |
| 320007091 | 320004044 | 1.56 | 76 | Palliative (P) | 2018-05-14 | 2018-05-14 | FLUOROURACIL + MITOMYCIN + RT | N | N | 320023860 | ICON8B TRIAL |
| 320007092 | 320004049 | null | 105.3 | Palliative (P) | 2018-01-20 | 2018-01-20 | AFLIBERCEPT + FU + IRINOTECAN | Y | null | 320023912 | VINBLASTINE |
| 320007093 | 320004053 | 1.73 | 80.8 | Palliative (P) | 2018-02-10 | 2018-03-07 | Cetuximab + Radiotherapy Maint | N | N | 320023924 | AFLIBERCEPT + FU + IRINOTECAN |
| 320007094 | 320004056 | 1.87 | 82.7 | Neo-adjuvant (N) | 2016-05-15 | 2016-06-18 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 320023942 | CISPLATIN + GEMCITABINE |
| 320007095 | 320004058 | 1.64 | 81.6 | Palliative (P) | 2017-02-04 | 2017-02-12 | OCTOPUS Trial | 2 | N | 320023958 | DOCETAXEL |
| 320007096 | 320004064 | 1.7 | 63.6 | Palliative (P) | 2017-04-11 | 2017-08-22 | Carboplatin + Docetaxel | N | N | 320024003 | CAV |
| 320007097 | 320004070 | 1.81 | 75.15 | Palliative (P) | 2013-11-30 | 2013-11-30 | CNS Low Grade Glioma Vinblastine | N | N | 320024027 | CAPECITABINE + CARBOPLATIN |
| 320007098 | 320004076 | 1.76 | 81.9 | Curative (C) | 2017-09-30 | 2017-09-30 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 320024052 | PEMBROLIZUMAB |
| 320007099 | 320005869 | 1.73 | 47.5 | Curative (C) | 2016-12-04 | 2017-02-28 | Topotecan (intravenous) | 02 | N | 320024075 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007100 | 320004083 | null | 78 | Palliative (P) | 2017-01-18 | 2017-01-27 | CARBOPLATIN + ETOPOSIDE | N | N | 320024088 | NIVOLUMAB |
| 320007101 | 320004087 | null | 79.2 | null | 2017-01-06 | 2017-01-07 | Folfirinox | 02 | N | 320025218 | DOXORUBICIN + GEMCITABINE |
| 320007102 | 320007399 | 1.58 | null | Palliative (P) | 2018-12-22 | 2018-12-24 | ICON8 TRIAL | 01 | N | 320002615 | CAPECITABINE + OXALIPLATIN |
| 320007103 | 320005882 | 1.7 | 69 | Adjuvant (A) | 2016-11-17 | 2016-11-20 | NIVOLUMAB | N | Y | 320004866 | CISPLATIN + GEMCITABINE |
| 320007104 | 320004111 | 1.61 | 50 | Palliative (P) | 2013-06-02 | 2014-04-25 | IVADo | N | N | 320004917 | ICON8B TRIAL |
| 320007105 | 320004119 | 1.53 | 37.2 | Palliative (P) | null | 2017-09-28 | Bevacizumab+Carbo+Pacliaxel | null | null | 320007716 | ETOPOSIDE |
| 320007106 | 320006725 | null | 73 | Palliative (P) | 2016-02-25 | 2016-02-25 | IBRUTINIB | 2 | N | 320007731 | ECX |
| 320007107 | 320004122 | 1.77 | 78 | Palliative (P) | 2017-10-31 | 2018-03-03 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 320007896 | CETUXIMAB + CISPLATIN + FU |
| 320007108 | 320004127 | 1.82 | 74 | Palliative (P) | 2016-11-26 | 2017-01-03 | Docetaxel 75mg/m2 (21 day) | N | N | 320008270 | RMS 2005 TRIAL |
| 320007109 | 320004128 | 1.54 | null | Palliative (P) | 2015-12-23 | 2016-05-13 | Bevacizumab+Carbo+Gemcitabine | N | N | 320008313 | BCG |
| 320007110 | 320007127 | 1.84 | 70.7 | Palliative (P) | 2016-02-19 | 2018-05-02 | Vemurafenib | 2 | N | 320008744 | DOCETAXEL |
| 320007111 | 320004142 | 1.51 | null | Neo-adjuvant (N) | 2016-11-03 | 2016-11-08 | Carboplatin + Docetaxel | N | N | 320008755 | CETUXIMAB + RT |
| 320007112 | 320004145 | 1.72 | 84 | Curative (C) | 2017-02-20 | 2017-08-07 | Carboplatin + Cetuximab (>Cycle 2) | N | N | 320008864 | CARBOPLATIN + CETUXIMAB + FU |
| 320007113 | 320004150 | null | 81.6 | Palliative (P) | 2017-10-31 | 2018-02-26 | GEMCITABINE + TIP | 2 | N | 320008881 | CAPECITABINE + IRINOTECAN |
| 320007114 | 320004152 | 1.59 | 45.5 | Palliative (P) | 2018-01-30 | 2018-03-23 | ICON8B TRIAL | 2 | N | 320009166 | NIVOLUMAB |
| 320007115 | 320004154 | 1.84 | 69.1 | Palliative (P) | 2017-02-01 | 2017-02-01 | PEMBROLIZUMAB | 02 | N | 320009201 | Y-90 |
| 320007116 | 320004155 | 1.7 | 93.6 | Curative (C) | 2018-10-30 | 2018-11-06 | BCG Intravesical | null | null | 320009451 | CARBOPLATIN + RT |
| 320007117 | 320007130 | 1.78 | 83.7 | Palliative (P) | 2016-07-05 | 2016-12-18 | PEMBROLIZUMAB | 02 | N | 320009502 | CISPLATIN + GEMCITABINE |
| 320007118 | 320004167 | null | 74 | Palliative (P) | 2016-05-23 | 2016-07-28 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | N | null | 320011028 | CISPLATIN + GEMCITABINE |
| 320007119 | 320004180 | 1.74 | 83.9 | Curative (C) | 2019-02-19 | 2019-06-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 320012188 | TEMOZOLOMIDE |
| 320007120 | 320004183 | 1.81 | 81.6 | Palliative (P) | 2019-01-09 | 2019-01-09 | Bevacizumab + Cape + Oxali 21day | N | N | 320012197 | CETUXIMAB + CISPLATIN + FU |
| 320007121 | 320005925 | 1.72 | null | Palliative (P) | 2018-11-25 | 2018-11-25 | IVA | N | N | 320013895 | AFLIBERCEPT + FU + IRINOTECAN |
| 320007122 | 320004203 | null | 51.4 | Palliative (P) | 2017-03-03 | 2017-05-11 | ICON8B TRIAL | null | null | 320015925 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007123 | 320005934 | 1.62 | 72.4 | Palliative (P) | 2016-08-31 | 2016-08-31 | GEMCITABINE + TIP | N | N | 320018048 | CYCLOPHOSPHAMIDE |